Publicacións en colaboración con investigadores/as de University College London (134)

2025

  1. Trajectory analysis of hepatic stellate cell differentiation reveals metabolic regulation of cell commitment and fibrosis

    Nature Communications , Vol. 16, Núm. 1

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson’s patients

    EMBO Molecular Medicine, Vol. 16, Núm. 7, pp. 1657-1674

  3. Challenges for the Implementation of Primary Standard Dosimetry in Proton Minibeam Radiation Therapy

    Cancers, Vol. 16, Núm. 23

  4. Clinical Benefits of 3D Printing in Healthcare

    3D Printing of Pharmaceutical and Drug Delivery Devices: Progress from Bench to Bedside (wiley), pp. 187-210

  5. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

  6. Performance of a Modular Ton-Scale Pixel-Readout Liquid Argon Time Projection Chamber

    Instruments, Vol. 8, Núm. 3

  7. The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis

    Metabolism: Clinical and Experimental, Vol. 158

  8. Visualizing disintegration of 3D printed tablets in humans using MRI and comparison with in vitro data

    Journal of Controlled Release, Vol. 365, pp. 348-357

2023

  1. 3D Printing of New Drugs Pharmaceutical Dosage Forms in Personalised Therapies

    3D Printing and Bioprinting for Pharmaceutical and Medical Applications (CRC Press), pp. 23-42

  2. A case study on decentralized manufacturing of 3D printed medicines

    International Journal of Pharmaceutics: X, Vol. 5

  3. A second update on mapping the human genetic architecture of COVID-19

    Nature

  4. Author Correction: Butler enables rapid cloud-based analysis of thousands of human genomes (Nature Biotechnology, (2020), 38, 3, (288-292), 10.1038/s41587-019-0360-3)

    Nature Biotechnology

  5. Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing (Nature Genetics, (2020), 52, 3, (331-341), 10.1038/s41588-019-0576-7)

    Nature Genetics

  6. Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers (Nature Genetics, (2020), 52, 3, (342-352), 10.1038/s41588-019-0557-x)

    Nature Genetics

  7. Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers (Nature Genetics, (2020), 52, 3, (342-352), 10.1038/s41588-019-0557-x)

    Nature Genetics

  8. Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer (Nature Genetics, (2020), 52, 3, (294-305), 10.1038/s41588-019-0564-y)

    Nature Genetics

  9. Author Correction: Genomic basis for RNA alterations in cancer (Nature, (2020), 578, 7793, (129-136), 10.1038/s41586-020-1970-0)

    Nature

  10. Author Correction: Pan-cancer analysis of whole genomes (Nature, (2020), 578, 7793, (82-93), 10.1038/s41586-020-1969-6)

    Nature

  11. Author Correction: Patterns of somatic structural variation in human cancer genomes (Nature, (2020), 578, 7793, (112-121), 10.1038/s41586-019-1913-9)

    Nature